EB Research Partnership
  • Epidermolysis Bullosa
    • What is EB?
    • Life with EB
    • Resources
  • Research
    • Our Impact
    • Scientific Advisory Board
    • Clinical Trials
    • Community Council
    • Apply for a Grant
  • Get Involved
    • Donate
    • Sponsor
    • EB Active
    • Events >
      • Venture Into Cures
    • The Effect
    • Shop
    • Accelerator Fund
  • Media
    • Press
    • Videos
  • About Us
    • Our Mission
    • Financials
    • Venture Philanthropy
    • Supporter Spotlight
    • Leadership >
      • Board of Directors
      • Staff
      • Founders
  • Donate
Epidermolysis Bullosa (EB) is a family of life-threatening rare genetic disorders that affect the body's largest organ: the skin.
Individuals with EB lack critical proteins that bind the skin's two layers together. Without these proteins, the skin tears apart, blisters, and shears off, leading to severe pain, disfigurement, and internal and external wounds that may never heal.

Today, there are no treatments or cures available for EB.
EBRP is dedicated to changing that.

Types of EB

​There are four main types of EB that vary in severity and the location of blister formation. In the more severe forms of EB, life expectancy ranges from early infancy to just 30 years of age. Click below to learn more about each type and meet an individual living with it.
Picture
Picture
Picture
Picture

heredity of eb

Genetic disorders, like EB, are usually passed down from parents to offspring. However, they also can be caused by a spontaneous DNA mutation in extremely rare cases. EBS and DDEB are passed down through dominant inheritance. This means only one copy of the mutated gene, from either the mother or father, is needed for a child to express the disorder. RDEB, JEB, and Kindler Syndrome are all passed down through recessive inheritance. This means that a child needs to get 2 copies of the mutated gene, one from each parent, to express the disease. Children can also be carriers of the gene, which means they're able to pass it down to their children, but do not express the disorder.
Picture
Picture

Sources

“Epidermolysis Bullosa Simplex - Genetics Home Reference - NIH.” U.S. National Library of Medicine, National Institutes of Health,  2018, ghr.nlm.nih.gov/condition/epidermolysis-bullosa-simplex.
“Junctional Epidermolysis Bullosa - Genetics Home Reference - NIH.” U.S. National Library of Medicine, National Institutes of Health, 2018, ghr.nlm.nih.gov/condition/junctional-epidermolysis-bullosa.​​
“Dystrophic Epidermolysis Bullosa - Genetics Home Reference - NIH.” U.S. National Library of Medicine, National Institutes of Health, 2018, ghr.nlm.nih.gov/condition/dystrophic-epidermolysis-bullosa.
“Kindler Syndrome - Genetics Home Reference - NIH.” U.S. National Library of Medicine, National Institutes of Health, 2018, ghr.nlm.nih.gov/condition/kindler-syndrome.
“Dominant Dystrophic Epidermolysis Bullosa.” Genetic and Rare Diseases Information Center, U.S. Department of Health and Human Services, rarediseases.info.nih.gov/diseases/2139/dominant-dystrophic-epidermolysis-bullosa.
Yancey, Kim B., and Helmut Hintner. "Non-herlitz junctional epidermolysis bullosa." Dermatologic clinics 28.1 (2010): 67-77.

EB Research Partnership

244 Madison Ave Ste 104
New York, NY 10016 
info@ebresearch.org
646-844-0902
Careers

Contact Us
​

Donor Privacy Policy
Donate

​Our Mission

​
Shop

Press
Picture

COPYRIGHT @2022 EB RESEARCH PARTNERSHIP. ALL RIGHTS RESERVED. EB RESEARCH PARTNERSHIP IS A 501(C)(3) NON PROFIT.

  • Epidermolysis Bullosa
    • What is EB?
    • Life with EB
    • Resources
  • Research
    • Our Impact
    • Scientific Advisory Board
    • Clinical Trials
    • Community Council
    • Apply for a Grant
  • Get Involved
    • Donate
    • Sponsor
    • EB Active
    • Events >
      • Venture Into Cures
    • The Effect
    • Shop
    • Accelerator Fund
  • Media
    • Press
    • Videos
  • About Us
    • Our Mission
    • Financials
    • Venture Philanthropy
    • Supporter Spotlight
    • Leadership >
      • Board of Directors
      • Staff
      • Founders
  • Donate